iremycin has been researched along with carmofur in 1 studies
| Studies (iremycin) | Trials (iremycin) | Recent Studies (post-2010) (iremycin) | Studies (carmofur) | Trials (carmofur) | Recent Studies (post-2010) (carmofur) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 254 | 46 | 45 |
| Protein | Taxonomy | iremycin (IC50) | carmofur (IC50) |
|---|---|---|---|
| Spike glycoprotein | Betacoronavirus England 1 | 1.82 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 1.82 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 1.82 | |
| Procathepsin L | Homo sapiens (human) | 1.82 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 1.82 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 1.82 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 1.82 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.5433 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 5 | |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 6.121 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 1.82 | |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.025 | |
| Acid ceramidase | Homo sapiens (human) | 0.3233 | |
| Acid ceramidase | Rattus norvegicus (Norway rat) | 0.029 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 1.82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
1 other study(ies) available for iremycin and carmofur
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |